SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details) |
12 Months Ended | ||||
---|---|---|---|---|---|
Mar. 01, 2018
USD ($)
|
Mar. 01, 2018
ZAR (R)
|
Nov. 30, 2019
USD ($)
shares
|
Nov. 30, 2018
USD ($)
shares
|
Nov. 30, 2017
USD ($)
shares
|
|
Finite-Lived Intangible Assets [Line Items] | |||||
Shipping and handling costs | $ 21,487 | $ 13,936 | |||
Advertising Expense | 366,786 | 262,248 | |||
Research and development expense | $ 158,105 | 164,162 | |||
Prepaid Advertising | $ 750,000 | ||||
Number of stock options | shares | 2,911,667 | 6,376,667 | 4,866,667 | ||
Warrants outstanding | shares | 45,787,219 | 26,041,160 | 20,941,160 | ||
Derivative Liability, Current | $ 0 | $ 957,301 | $ 539,860 | ||
Rephit (Pty) Ltd [Member] | |||||
Finite-Lived Intangible Assets [Line Items] | |||||
Purchases common shares | $ 300 | R 4,000 | |||
Patents [Member] | |||||
Finite-Lived Intangible Assets [Line Items] | |||||
Amortized estimated useful life patent | 15 years |
X | ||||||||||
- Definition Represents amount of shipping and handling costs. No definition available.
|
X | ||||||||||
- Definition Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Number of warrants or rights outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Definition The cash outflow associated with the acquisition of or advances to an entity that is related to it but not strictly controlled (for example, an unconsolidated subsidiary, affiliate, and joint venture or equity method investment) or the acquisition of an additional interest in a subsidiary (controlled entity). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of consideration paid in advance for advertising that provides economic benefits within a future period of one year or the normal operating cycle, if longer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|